Erchonia FX 635 Low-Level Laser Therapy Erchonia FX 635 Low-Level Laser Therapy uses low-level laser technology and patented laser diode arms to precisely target lower back pain centers. It reduces inflammation while promoting bio-stimulation at a cellular level in the musculoskeletal point of the pain’s origination. Unlike other lasers that are too strong and unreliable — and produce unwanted heat — fully compliant with ISO 13485 Medical Device Quality and IEC 60825-1 Laser Safety. Low level lasers FDA cleared to treat: Low back pain Plantar fasciitis Nociceptive musculoskeletal pain Highly effective for problems such as: Plantar Fasciitis and heel pain Back pain Neck pain Shoulder and arm pain Knee pain Elbow pain Chronic pain Patients who undergo this treatment have the peace of mind in knowing that they can expect: No Pain No Drugs No Side Effects No Downtime Fastest Way to Treat Plantar Fasciitis Now you can relieve the pain and inflammation of the heel associated with plantar fasciitis. Our new FDA market cleared laser has been proven in clinical tests to effectively treat this painful condition. The regenerative powers of this low level laser technology can reduce inflammation and eliminate pain in the plantar fascia in only a matter of weeks and help you return to an active life once again. Benefits of the Erchonia FX 635 For Your Practice Freestanding that allows you to see other patients while giving FX 635 treatments Completely automated, so you can save on staff cost and increase profits Marketable pain relief laser due to FDA/Health Canada Clearances (data sheet) Highly versatile and can treat a wide variety of conditions Purchase and leasing options available Easy to implement User friendly graphical user interface Benefits of the FX 635 for Your Patients Advantages of Low Level Laser Therapy for Clients: No pain No side effects Treatments are fast Can be used in conjunction with other treatments Highly effective Non Invasive Rapid recovery Targeted relief Has the quickest and most effective results, per clinical studies
